YCM
ENTA icon

Yousif Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Yousif Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,516
Closed -$385K – 1976
2023
Q1 		$385K Sell
9,516
-2,073
-18% -$99K 0.01% 1605
2022
Q4 		$539K Sell
11,589
-3,400
-23% -$155K 0.01% 1463
2022
Q3 		$777K Buy
14,989
+631
+4% +$36.9K 0.01% 1318
2022
Q2 		$679K Sell
14,358
-2,119
-13% -$115K 0.01% 1427
2022
Q1 		$1.17M Buy
16,477
+445
+3% +$29K 0.01% 1284
2021
Q4 		$1.2M Buy
+16,032
New +$1.26M 0.01% 1288

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Yousif Capital Management's ENTA Position: Q2 2023 in Review

Yousif Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2023, closing a stake of 9,516 shares — an estimated $385K sold.

Yousif Capital Management first reported a position in ENTA in Q4 2021 and held it in 6 quarters. The position peaked at $1.2M in Q4 2021. 133 funds tracked by Wall St. Rank hold ENTA as of Q2 2023.

  • Yousif Capital Management reported no remaining Enanta Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Yousif Capital Management sold 9,516 Enanta Pharmaceuticals shares in Q2 2023, an estimated $385K.
  • Yousif Capital Management first reported a position in Enanta Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • Yousif Capital Management's Enanta Pharmaceuticals position peaked at $1.2M in Q4 2021.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2023.

Based on Yousif Capital Management's 13F filing for Q2 2023, filed 2 Aug 2023.